These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24105738)

  • 1. A novel peptide specifically targeting ovarian cancer identified by in vivo phage display.
    Ma C; Yin G; Yan D; He X; Zhang L; Wei Y; Huang Z
    J Pept Sci; 2013 Dec; 19(12):730-6. PubMed ID: 24105738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell adhesion and invasion inhibitory effect of an ovarian cancer targeting peptide selected via phage display in vivo.
    Pu X; Ma C; Yin G; You F; Wei Y
    Biochem Biophys Res Commun; 2014 Jan; 443(3):858-63. PubMed ID: 24342617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo.
    Mueller J; Gaertner FC; Blechert B; Janssen KP; Essler M
    Mol Cancer Res; 2009 Jul; 7(7):1078-85. PubMed ID: 19584266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and identification of a peptide specifically targeted to NCI-H1299 from a phage display peptide library.
    Zang L; Shi L; Guo J; Pan Q; Wu W; Pan X; Wang J
    Cancer Lett; 2009 Aug; 281(1):64-70. PubMed ID: 19327883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery.
    Lee TY; Lin CT; Kuo SY; Chang DK; Wu HC
    Cancer Res; 2007 Nov; 67(22):10958-65. PubMed ID: 18006841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening of short peptides that bind specifically to ovarian cancer cell line through whole-cell subtraction biopanning].
    Zhou C; Kang J; Wang X; Nie M; Jiang W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Oct; 29(10):1098-101. PubMed ID: 24103273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide.
    Du B; Han H; Wang Z; Kuang L; Wang L; Yu L; Wu M; Zhou Z; Qian M
    Mol Cancer Res; 2010 Feb; 8(2):135-44. PubMed ID: 20145035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display.
    Lee SM; Lee EJ; Hong HY; Kwon MK; Kwon TH; Choi JY; Park RW; Kwon TG; Yoo ES; Yoon GS; Kim IS; Ruoslahti E; Lee BH
    Mol Cancer Res; 2007 Jan; 5(1):11-9. PubMed ID: 17259343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of the breast cancer cell-binding peptide, p160.
    Askoxylakis V; Zitzmann S; Mier W; Graham K; Krämer S; von Wegner F; Fink RH; Schwab M; Eisenhut M; Haberkorn U
    Clin Cancer Res; 2005 Sep; 11(18):6705-12. PubMed ID: 16166451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage display screening identifies a novel peptide to suppress ovarian cancer cells in vitro and in vivo in mouse models.
    Zhou C; Kang J; Wang X; Wei W; Jiang W
    BMC Cancer; 2015 Nov; 15():889. PubMed ID: 26555399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro screening of ovarian tumor specific peptides from a phage display peptide library.
    Zhang L; Yin G; Yan D; Wei Y; Ma C; Huang Z; Liao X; Yao Y; Chen X; Hao B
    Biotechnol Lett; 2011 Sep; 33(9):1729-35. PubMed ID: 21544611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia-targeting ligands isolated from phage-display peptide libraries.
    Jäger S; Jahnke A; Wilmes T; Adebahr S; Vögtle FN; Delima-Hahn E; Pfeifer D; Berg T; Lübbert M; Trepel M
    Leukemia; 2007 Mar; 21(3):411-20. PubMed ID: 17252013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel peptide probe for imaging and targeted delivery of liposomal doxorubicin to lung tumor.
    He X; Na MH; Kim JS; Lee GY; Park JY; Hoffman AS; Nam JO; Han SE; Sim GY; Oh YK; Kim IS; Lee BH
    Mol Pharm; 2011 Apr; 8(2):430-8. PubMed ID: 21222482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular targeting of atherosclerotic plaques by a stabilin-2-specific peptide ligand.
    Lee GY; Kim JH; Oh GT; Lee BH; Kwon IC; Kim IS
    J Control Release; 2011 Oct; 155(2):211-7. PubMed ID: 21781994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of a tumor-binding peptide identified by phage display to a functional chimeric T cell antigen receptor.
    Pameijer CR; Navanjo A; Meechoovet B; Wagner JR; Aguilar B; Wright CL; Chang WC; Brown CE; Jensen MC
    Cancer Gene Ther; 2007 Jan; 14(1):91-7. PubMed ID: 17024231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening peptides binding specifically to large intestinal cancer LoVo cells from phage random peptide library].
    Liao KX; Yao XQ; Wu CT; Lin F; Wu WL; Zeng SD; Luo YQ; Lei ST
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):986-90. PubMed ID: 18583245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery.
    Li ZJ; Wu WK; Ng SS; Yu L; Li HT; Wong CC; Wu YC; Zhang L; Ren SX; Sun XG; Chan KM; Cho CH
    J Control Release; 2010 Dec; 148(3):292-302. PubMed ID: 20854857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial cell surface vimentin binding peptide induces angiogenesis under hypoxic/ischemic conditions.
    Glaser-Gabay L; Raiter A; Battler A; Hardy B
    Microvasc Res; 2011 Nov; 82(3):221-6. PubMed ID: 21803052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel SRESPHP peptide mediates specific binding to primary medullary thyroid carcinoma after systemic injection.
    Böckmann M; Hilken G; Schmidt A; Cranston AN; Tannapfel A; Drosten M; Frilling A; Ponder BA; Pützer BM
    Hum Gene Ther; 2005 Nov; 16(11):1267-75. PubMed ID: 16259560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells.
    Shadidi M; Sioud M
    FASEB J; 2003 Feb; 17(2):256-8. PubMed ID: 12490548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.